Stories

Ginkgo Bioworks raises $275 million to design DNA

Gingko Bioworks' lab facility. Photo: Gingko Bioworks

Ginkgo Bioworks is in the business of designing and printing microbes, but it recently raised $275 million — bringing its valuation to over $1 billion — because it sees itself more akin to a software company.

Why it matters: The Boston-based company says that, by providing specialized services for designing, developing, and printing DNA, it can open possibilities for customers in industries outside of health care.